← Eichor
Condition: Nets Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Nets

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Dual-targeting Tracer TATE-RGD for the Diagnosis of SSTR- and RGD- Positive Tumors
EARLY_Phase 1 · 1 location(s) · Peking Union Medical College Hospital · NCT06632860Protocol ITANET - Registry
Phase N/A · 37 location(s) · Italian Association Neuroendocrine Tumors · NCT04282083Prophylactic Cholecystectomy in Midgut NETs Patients Who Require Primary Tumor Surgery.
NA · 6 location(s) · Hospital Universitari de Bellvitge · NCT04735198Immunothrombosis With Septic Shock Undergoing Renal Replacement Therapy With the OXIRIS Membrane
Phase N/A · 1 location(s) · University Hospital, Bordeaux · NCT0644031768Ga-DOTA-TATE PET/CT Imaging in NETs
Phase 3 · 2 location(s) · Centre de recherche du Centre hospitalier universitaire de S · NCT04847505Multi-modal Characterisation of Gastroenteropancreatic Neuroendocrine Tumours (GEP-NETs) Treated With Targeted Radionucl
NA · 5 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06256705Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.
Phase 1 · 9 location(s) · RayzeBio, Inc. · NCT07165132Sapu003 in Advanced mTOR-sensitive Solid Tumors
Phase 1 · 1 location(s) · SAPU NANO (US) LLC · NCT07369505Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
Phase 3 · 65 location(s) · Novartis Pharmaceuticals · NCT06784752Effect of OFA, OSA Versus Opioid-based Anesthesia on NETs and Cancer Cell Malignancy After Colorectal Cancer Surgery
NA · 1 location(s) · Fudan University · NCT07264556A Phase III Clinical Study to Compare the Safety and Efficacy of 177Lu-DOTATATE Injection and Long-acting Oxytrexine in
Phase 3 · 1 location(s) · HTA Co., Ltd. · NCT07057622Life Following Excision of Neuroendocrine Tumors
Phase N/A · 1 location(s) · Sunnybrook Health Sciences Centre · NCT06981455Metronomic Temozolomide in Unfit NENs Patients Metronomic Temozolomide in Unfit Patients With Advanced Neuroendocrine Ne
Phase 2 · 1 location(s) · European Institute of Oncology · NCT05554003Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric P
Phase 1 · 5 location(s) · ITM Solucin GmbH · NCT06441331Value of Right-sided Hemicolectomy for Chldren With High-risk Neuroendocrine Tumors of the Appendix
Phase N/A · 1 location(s) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC · NCT05919758Endoscopic Ultrasound-guided Radiofrequency Ablation for Upper Gastrointestinal Tract Lesions
Phase N/A · 1 location(s) · Herlev Hospital · NCT07272187Clonal Hematopoiesis and NETs Formation in Venous Thrombosis (CLODETTE)
NA · 7 location(s) · University Hospital, Bordeaux · NCT05711173Sirolimus for Injection (Albumin Bound) Combined With Octreotide Long-acting Injection in Patients With Metastatic Gastr
Phase 2/Phase 3 · 1 location(s) · CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · NCT07165886Impact of Antiglycemic & Immunosuppressive Therapies on NETosis in Diabetes & Kidney Disease (NETs - Neutrophil Traps)
Phase N/A · 1 location(s) · Western Galilee Hospital-Nahariya · NCT06821919Randomized Interval Assessment Trial of Lu177-Dotatate in Slowly Progressive G1-2 Advanced Midgut Neuroendocrine Tumors
Phase 3 · 21 location(s) · Grupo Espanol de Tumores Neuroendocrinos · NCT06878664NETs: Protection or Harm in Neonatal Inflammation or Infection
Phase N/A · 1 location(s) · University of Utah · NCT00747851Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 17
Phase 3 · 54 location(s) · RayzeBio, Inc. · NCT05477576Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract,
Phase 2 · 4 location(s) · Aadi Bioscience, Inc. · NCT05997056
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.